436 related articles for article (PubMed ID: 22008893)
21. Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C without sustained response to combination therapy.
Chang KC; Ye YH; Wu CK; Lin MT; Tsai MC; Tseng PL; Hu TH
J Formos Med Assoc; 2018 Nov; 117(11):1011-1018. PubMed ID: 29254684
[TBL] [Abstract][Full Text] [Related]
22. Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index.
Lee K; Sinn DH; Gwak GY; Cho HC; Jung SH; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Gut Liver; 2016 Sep; 10(5):796-802. PubMed ID: 27114418
[TBL] [Abstract][Full Text] [Related]
23. Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan.
Akuta N; Kawamura Y; Suzuki F; Saitoh S; Arase Y; Kunimoto H; Sorin Y; Fujiyama S; Sezaki H; Hosaka T; Kobayashi M; Suzuki Y; Kobayashi M; Ikeda K; Kumada H
Hepatol Int; 2016 Jul; 10(4):647-56. PubMed ID: 27074850
[TBL] [Abstract][Full Text] [Related]
24. Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.
Hann HW; Wan S; Lai Y; Hann RS; Myers RE; Patel F; Zhang K; Ye Z; Wang C; Yang H
J Gastroenterol Hepatol; 2015 Jan; 30(1):131-138. PubMed ID: 24995497
[TBL] [Abstract][Full Text] [Related]
25. Cancer Risk in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.
Simon TG; Roelstraete B; Sharma R; Khalili H; Hagström H; Ludvigsson JF
Hepatology; 2021 Nov; 74(5):2410-2423. PubMed ID: 33811766
[TBL] [Abstract][Full Text] [Related]
26. Non-alcoholic fatty liver disease (NAFLD) fibrosis score predicts 6.6-year overall mortality of Chinese patients with NAFLD.
Xun YH; Guo JC; Lou GQ; Jiang YM; Zhuang ZJ; Zhu MF; Luo Y; Ma XJ; Liu J; Bian DX; Shi JP
Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):643-9. PubMed ID: 24837195
[TBL] [Abstract][Full Text] [Related]
27. Suboptimal performance of simple noninvasive tests for advanced fibrosis in Chinese patients with nonalcoholic fatty liver disease.
Xun YH; Fan JG; Zang GQ; Liu H; Jiang YM; Xiang J; Huang Q; Shi JP
J Dig Dis; 2012 Nov; 13(11):588-95. PubMed ID: 23107446
[TBL] [Abstract][Full Text] [Related]
28. The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease.
Lee TY; Wu JC; Yu SH; Lin JT; Wu MS; Wu CY
Int J Cancer; 2017 Oct; 141(7):1307-1314. PubMed ID: 28509327
[TBL] [Abstract][Full Text] [Related]
29. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
[TBL] [Abstract][Full Text] [Related]
30. Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease.
Bertot LC; Jeffrey GP; de Boer B; MacQuillan G; Garas G; Chin J; Huang Y; Adams LA
Liver Int; 2018 Oct; 38(10):1793-1802. PubMed ID: 29575516
[TBL] [Abstract][Full Text] [Related]
31. The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease.
Arase Y; Suzuki F; Kobayashi M; Suzuki Y; Kawamura Y; Matsumoto N; Akuta N; Kobayashi M; Sezaki H; Saito S; Hosaka T; Ikeda K; Kumada H; Ohmoto Y; Amakawa K; Tsuji H; Hsieh SD; Kato K; Tanabe M; Ogawa K; Hara S; Kobayashi T
Intern Med; 2011; 50(10):1081-7. PubMed ID: 21576832
[TBL] [Abstract][Full Text] [Related]
32. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
[TBL] [Abstract][Full Text] [Related]
33. Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease.
Kanwal F; Kramer JR; Mapakshi S; Natarajan Y; Chayanupatkul M; Richardson PA; Li L; Desiderio R; Thrift AP; Asch SM; Chu J; El-Serag HB
Gastroenterology; 2018 Dec; 155(6):1828-1837.e2. PubMed ID: 30144434
[TBL] [Abstract][Full Text] [Related]
34. Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.
Hashimoto E; Yatsuji S; Tobari M; Taniai M; Torii N; Tokushige K; Shiratori K
J Gastroenterol; 2009; 44 Suppl 19():89-95. PubMed ID: 19148800
[TBL] [Abstract][Full Text] [Related]
35. Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey.
Tokushige K; Hashimoto E; Horie Y; Taniai M; Higuchi S
J Gastroenterol; 2011 Oct; 46(10):1230-7. PubMed ID: 21748549
[TBL] [Abstract][Full Text] [Related]
36. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.
Ascha MS; Hanouneh IA; Lopez R; Tamimi TA; Feldstein AF; Zein NN
Hepatology; 2010 Jun; 51(6):1972-8. PubMed ID: 20209604
[TBL] [Abstract][Full Text] [Related]
37. Prevalence, gender, ethnic variations, and prognosis of NASH.
Hashimoto E; Tokushige K
J Gastroenterol; 2011 Jan; 46 Suppl 1():63-9. PubMed ID: 20844903
[TBL] [Abstract][Full Text] [Related]
38. Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study.
Alexander J; Torbenson M; Wu TT; Yeh MM
J Gastroenterol Hepatol; 2013 May; 28(5):848-54. PubMed ID: 23302015
[TBL] [Abstract][Full Text] [Related]
39. Clinical utility of simple non-invasive liver fibrosis indices for predicting hepatocellular carcinoma (HCC) among Egyptian patients.
Abdelgawad IA
J Clin Pathol; 2015 Feb; 68(2):154-60. PubMed ID: 25430496
[TBL] [Abstract][Full Text] [Related]
40. Low HDL-cholesterol levels predict hepatocellular carcinoma development in individuals with liver fibrosis.
Crudele L; De Matteis C; Piccinin E; Gadaleta RM; Cariello M; Di Buduo E; Piazzolla G; Suppressa P; Berardi E; Sabbà C; Moschetta A
JHEP Rep; 2023 Jan; 5(1):100627. PubMed ID: 36561127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
